Report cover image

Companion Animal Health Market by Animal (Cats, Dogs, Horses), Indication (Behavioral Disorders, Dental Diseases, Dermatologic Diseases), Type, End-Use, Distribution Channel - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 185 Pages
SKU # IRE18437431

Description

Companion Animal Health Market by Animal (Cats, Dogs, Horses), Indication (Behavioral Disorders, Dental Diseases, Dermatologic Diseases), Type, End-Use, Distribution Channel - Global Forecast 2024-2030


The Companion Animal Health Market size was estimated at USD 33.76 billion in 2023 and expected to reach USD 39.72 billion in 2024, at a CAGR 17.73% to reach USD 105.92 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Companion Animal Health Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Companion Animal Health Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Health Market, highlighting leading vendors and their innovative profiles. These include Alcami Corporation, B. Braun Melsungen AG, Bayer AG, Bioiberica S.A.U., Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Cozmix Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Elanco US, Inc., Eli Lilly and Company, IDEXX Laboratories, Inc., Medtronic PLC, Merck & Co., Inc., Nutreco N.V., Perrigo Company PLC, Vetoquinol SA, Virbac SA, and Zoetis, Inc..

Market Segmentation & Coverage


This research report categorizes the Companion Animal Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

Animal
Cats
Dogs
Horses
Indication
Behavioral Disorders
Dental Diseases
Dermatologic Diseases
Infectious Diseases
Orthopedic Diseases
Type
Medicinal Additive Feed
Amino Acids

Minerals

Vitamins
Nutritional Feed Additives
Enzymes

Feed Acidifiers

Hormones

Immune Modulators

Prebiotics & Probiotics
Pharmaceuticals
Anti-Inflammatory

Antibiotics

Ectoparasiticides

Endoparasiticides
Vaccines
End-Use
Point-of-care Testing or In-house Testing
Veterinary Hospitals & Clinics
Distribution Channel
E-commerce
Hospital Pharmacies
Retail
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Companion Animal Health Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Companion Animal Health Market?
3. What are the technology trends and regulatory frameworks in the Companion Animal Health Market?
4. What is the market share of the leading vendors in the Companion Animal Health Market?
5. Which modes and strategic moves are suitable for entering the Companion Animal Health Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

185 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Companion Animal Health Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing initiatives by government and animal welfare associations
5.1.1.2. Technological advancements in the field of animal healthcare
5.1.1.3. Changing the perception of the consumers toward pet health and longer life expectancy for companion animal
5.1.1.4. Increasing disposable incomes and pet owners afford to spend more on pet healthcare
5.1.1.5. Increasing online shopping and home delivery is driving the product sale
5.1.2. Restraints
5.1.2.1. Increase in cheap counterfeit drugs
5.1.2.2. Lack of infrastructure, funding, and standardization
5.1.3. Opportunities
5.1.3.1. Increase in cheap counterfeit drugs
5.1.3.2. Lack of infrastructure, funding, and standardization
5.1.4. Challenges
5.1.4.1. Prohibition on the use of antibiotics and antimicrobials in animal feed in many countries,
5.1.4.2. High cost associated with animal testing and veterinary in developing countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Companion Animal Health Market, by Animal
6.1. Introduction
6.2. Cats
6.3. Dogs
6.4. Horses
7. Companion Animal Health Market, by Indication
7.1. Introduction
7.2. Behavioral Disorders
7.3. Dental Diseases
7.4. Dermatologic Diseases
7.5. Infectious Diseases
7.6. Orthopedic Diseases
8. Companion Animal Health Market, by Type
8.1. Introduction
8.2. Medicinal Additive Feed
8.3.1. Amino Acids
8.3.2. Minerals
8.3.3. Vitamins
8.3. Nutritional Feed Additives
8.4.1. Enzymes
8.4.2. Feed Acidifiers
8.4.3. Hormones
8.4.4. Immune Modulators
8.4.5. Prebiotics & Probiotics
8.4. Pharmaceuticals
8.5.1. Anti-Inflammatory
8.5.2. Antibiotics
8.5.3. Ectoparasiticides
8.5.4. Endoparasiticides
8.5. Vaccines
9. Companion Animal Health Market, by End-Use
9.1. Introduction
9.2. Point-of-care Testing or In-house Testing
9.3. Veterinary Hospitals & Clinics
10. Companion Animal Health Market, by Distribution Channel
10.1. Introduction
10.2. E-commerce
10.3. Hospital Pharmacies
10.4. Retail
11. Americas Companion Animal Health Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Companion Animal Health Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Companion Animal Health Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Alcami Corporation
15.1.2. B. Braun Melsungen AG
15.1.3. Bayer AG
15.1.4. Bioiberica S.A.U.
15.1.5. Boehringer Ingelheim GmbH
15.1.6. Ceva Sante Animale S.A.
15.1.7. Cozmix Inc.
15.1.8. Dechra Pharmaceuticals PLC
15.1.9. Elanco Animal Health Incorporated
15.1.10. Elanco US, Inc.
15.1.11. Eli Lilly and Company
15.1.12. IDEXX Laboratories, Inc.
15.1.13. Medtronic PLC
15.1.14. Merck & Co., Inc.
15.1.15. Nutreco N.V.
15.1.16. Perrigo Company PLC
15.1.17. Vetoquinol SA
15.1.18. Virbac SA
15.1.19. Zoetis, Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. COMPANION ANIMAL HEALTH MARKET RESEARCH PROCESS
FIGURE 2. COMPANION ANIMAL HEALTH MARKET SIZE, 2023 VS 2030
FIGURE 3. COMPANION ANIMAL HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COMPANION ANIMAL HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COMPANION ANIMAL HEALTH MARKET DYNAMICS
FIGURE 7. COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
FIGURE 8. COMPANION ANIMAL HEALTH MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. COMPANION ANIMAL HEALTH MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 12. COMPANION ANIMAL HEALTH MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. COMPANION ANIMAL HEALTH MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. COMPANION ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES COMPANION ANIMAL HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. COMPANION ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. COMPANION ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us